FEMY
Femasys Inc
NASDAQ: FEMY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.37
-2.06% today
Updated 2026-04-30
Market cap
$24.58M
P/E ratio
—
P/S ratio
10.72x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$0 – $1
Volume
0.5M
Femasys Inc (FEMY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.01M | $-4.93M | $-7.93M | $-10.73M | $-11.28M | $-19.44M | $-18.69M |
| Capital expenditures | $696499.00 | $31681.00 | $306868.00 | $407475.00 | $143917.00 | $761706.00 | $525007.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $358841.00 | $318640.00 | $193366.00 | $224939.00 | $675700.00 | $444147.00 | $790145.00 |
| Free cash flow | $-11.70M | $-4.96M | $-8.24M | $-11.14M | $-11.42M | $-20.21M | $-19.22M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |